182 related articles for article (PubMed ID: 9782457)
1. On the action of botulinum neurotoxins A and E at cholinergic terminals.
Washbourne P; Pellizzari R; Rossetto O; Bortoletto N; Tugnoli V; De Grandis D; Eleopra R; Montecucco C
J Physiol Paris; 1998 Apr; 92(2):135-9. PubMed ID: 9782457
[TBL] [Abstract][Full Text] [Related]
2. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
Washbourne P; Pellizzari R; Baldini G; Wilson MC; Montecucco C
FEBS Lett; 1997 Nov; 418(1-2):1-5. PubMed ID: 9414082
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
Raciborska DA; Trimble WS; Charlton MP
Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
[TBL] [Abstract][Full Text] [Related]
4. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
Lawrence GW; Foran P; Mohammed N; DasGupta BR; Dolly JO
Biochemistry; 1997 Mar; 36(11):3061-7. PubMed ID: 9115981
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
6. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
Dolly JO; Wang J; Zurawski TH; Meng J
FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
[TBL] [Abstract][Full Text] [Related]
8. Botulinum neurotoxin E-insensitive mutants of SNAP-25 fail to bind VAMP but support exocytosis.
Washbourne P; Bortoletto N; Graham ME; Wilson MC; Burgoyne RD; Montecucco C
J Neurochem; 1999 Dec; 73(6):2424-33. PubMed ID: 10582602
[TBL] [Abstract][Full Text] [Related]
9. Syntaxin and 25-kDa synaptosomal-associated protein: differential effects of botulinum neurotoxins C1 and A on neuronal survival.
Williamson LC; Neale EA
J Neurosci Res; 1998 Jun; 52(5):569-83. PubMed ID: 9632313
[TBL] [Abstract][Full Text] [Related]
10. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins.
Pellizzari R; Rossetto O; Lozzi L; Giovedi' S; Johnson E; Shone CC; Montecucco C
J Biol Chem; 1996 Aug; 271(34):20353-8. PubMed ID: 8702770
[TBL] [Abstract][Full Text] [Related]
11. Molecular targets of botulinum toxin at the mammalian neuromuscular junction.
Whelchel DD; Brehmer TM; Brooks PM; Darragh N; Coffield JA
Mov Disord; 2004 Mar; 19 Suppl 8():S7-S16. PubMed ID: 15027049
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
Foran P; Lawrence GW; Shone CC; Foster KA; Dolly JO
Biochemistry; 1996 Feb; 35(8):2630-6. PubMed ID: 8611567
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
Zanetti G; Sikorra S; Rummel A; Krez N; Duregotti E; Negro S; Henke T; Rossetto O; Binz T; Pirazzini M
PLoS Pathog; 2017 Aug; 13(8):e1006567. PubMed ID: 28800600
[TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxin B inhibits insulin-stimulated glucose uptake into 3T3-L1 adipocytes and cleaves cellubrevin unlike type A toxin which failed to proteolyze the SNAP-23 present.
Chen F; Foran P; Shone CC; Foster KA; Melling J; Dolly JO
Biochemistry; 1997 May; 36(19):5719-28. PubMed ID: 9153412
[TBL] [Abstract][Full Text] [Related]
15. Uptake of botulinum neurotoxin into cultured neurons.
Keller JE; Cai F; Neale EA
Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of intracellular substrates of botulinum toxins A, C, and D in a mammalian target tissue.
Kalandakanond S; Coffield JA
J Pharmacol Exp Ther; 2001 Mar; 296(3):749-55. PubMed ID: 11181902
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
18. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.
Binz T; Blasi J; Yamasaki S; Baumeister A; Link E; Südhof TC; Jahn R; Niemann H
J Biol Chem; 1994 Jan; 269(3):1617-20. PubMed ID: 8294407
[TBL] [Abstract][Full Text] [Related]
19. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
20. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
Adler M; Keller JE; Sheridan RE; Deshpande SS
Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
